跳至主要内容
临床试验/ACTRN12621001329853
ACTRN12621001329853招募中2 期

Safety and Efficacy of Preoperative Stereotactic Radiosurgery for Treatment of Brain Metastases: A Phase II Study

Western Sydney Local Health District0 个研究点目标入组 30 人开始时间: 2021年9月29日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged 18 years or older.
  • ECOG Performance Status 0, 1 or 2.
  • Life expectancy at least 6 months.
  • Prior histopathological diagnosis of cancer other than small cell lung cancer, lymphoma, and germ cell tumours.
  • MRI of the brain with findings strongly suggestive of metastatic tumour(s) as assessed by the radiologist.
  • MRI evidence of single or multiple BM lesions amenable for SRS as discussed both by Radiation Oncologist and Neurosurgeon.

排除标准

  • Not a surgical candidate per neurosurgeon's discretion.
  • Disseminated intracranial or leptomeningeal disease.
  • Neurologically unstable patients or requiring emergent surgical decompression.
  • Patients with Brain Metastases 5cm or larger.
  • Cytotoxic Chemotherapy within 7 days prior to SRS.
  • Anti-Vascular endothelial growth factor (VEGF) therapy within 6 weeks of SRS (risk of fatal brain haemorrhage with surgical resection).
  • Inability to tolerate SRS (ie, the inability to lie flat in treatment bed).
  • Contraindication for MRI.

研究者

相似试验

招募中
1 期
A phase II study of preoperative stereotactic radiation therapy boost combined with short-course immunotherapy (pembrolizumab versus placebo, randomized, double-blind) and standard chemotherapy in patients with newly diagnosed HER2-negative non-metastatic breast cancer with lack of early metabolic response in 18-fluorodeoxyglucoseFDG-PET/CT after 1st chemoterapy cycleHER2 negative breast cancerMedDRA version: 23.0Level: PTClassification code: 10083232Term: HER2 negative breast cancer Class: 100000004864
CTIS2023-504145-31-00arodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy78
进行中(未招募)
不适用
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain MetastasesBrain Metastases, Adult
NCT05341739Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)20
尚未招募
4 期
Efficacy of stereotactic radiosurgery based on three-dimensional rotational angiography for cerebrovascular malformatioBrain arteriovenous malformationcerebrovascular disease, cerebrovascular malformationD002538
JPRN-jRCT1032230589mekawa Motoyuki60
招募中
1 期
Preoperative fractionated Stereotactic Radiosurgery for Breast Cancer (PROBE)C50Malignant neoplasm of breast
DRKS00014558Städtisches Klinikum Dessau50
招募中
不适用
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of ExtremitiesSoft Tissue SarcomaStereotactic Body RadiotherapySurgery
NCT06760221Second Affiliated Hospital, School of Medicine, Zhejiang University20